MedTrace Logo

Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy

NCT00482586 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 137

Last updated 2015-06-08

No results posted yet for this study

Summary

RATIONALE: Gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy may help the study of cancer in the future.

PURPOSE: This clinical trial is gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy.

Conditions

Interventions

OTHER

medical chart review

Review the medical charts of patients with hepatic neoplasms who undergo Image-guided Therapy.

OTHER

questionnaire administration

Patients with hepatic neoplasms who undergo Image-guided Therapy

PROCEDURE

quality-of-life assessment

Patients with hepatic neoplasms who undergo Image-guided Therapy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Steven G. Meranze, MD · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00482586 on ClinicalTrials.gov